What is Looxid Labs?
Looxid Labs is at the forefront of developing advanced AI solutions that leverage electroencephalography (EEG) and biometric data. Their innovative technology finds applications across a diverse range of industries, including healthcare, education, insurance, and wellness. The company's product portfolio features the Link Band 2.0, a sophisticated yet lightweight EEG device, Mind Breeze, a premium meditation class service designed to enhance mental well-being, and Focus Mate, an AI-powered application aimed at improving concentration. Through strategic partnerships, Looxid Labs is dedicated to creating practical innovations that address real-world challenges by integrating neuroscience and artificial intelligence.
How much funding has Looxid Labs raised?
Looxid Labs has raised a total of $4M across 1 funding round:
Series A
$4M
Series A (2018): $4M with participation from Hastings Asset Management
Key Investors in Looxid Labs
Hastings Asset Management
Hastings Asset Management is an investment firm that likely focuses on strategic capital allocation across various sectors, potentially including technology and healthcare.
What's next for Looxid Labs?
The substantial enterprise-level capital infusion positions Looxid Labs for accelerated growth and market expansion. This strategic investment, likely a Series A financing given the context, will enable the company to further refine its AI algorithms, enhance its product offerings such as the Link Band 2.0 and Focus Mate, and broaden its reach within the healthcare and wellness technology markets. Future developments may include deeper integration of EEG and biometric data for personalized cognitive health solutions and increased collaboration with enterprise clients seeking to boost employee productivity and well-being through neurotechnology.
See full Looxid Labs company page
